JP2005500029A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005500029A5 JP2005500029A5 JP2003503798A JP2003503798A JP2005500029A5 JP 2005500029 A5 JP2005500029 A5 JP 2005500029A5 JP 2003503798 A JP2003503798 A JP 2003503798A JP 2003503798 A JP2003503798 A JP 2003503798A JP 2005500029 A5 JP2005500029 A5 JP 2005500029A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- nucleotide sequence
- group
- amino acid
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0107588A FR2825716B1 (fr) | 2001-06-11 | 2001-06-11 | Nouveaux polynucleotides et polypeptides de l'ifn alpha 7 |
| PCT/EP2002/007456 WO2002101048A2 (en) | 2001-06-11 | 2002-06-11 | NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005500029A JP2005500029A (ja) | 2005-01-06 |
| JP2005500029A5 true JP2005500029A5 (https=) | 2005-09-22 |
Family
ID=8864156
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003503798A Pending JP2005500029A (ja) | 2001-06-11 | 2002-06-11 | ＩＦＮα−７遺伝子の新規ポリヌクレオチド及びポリペプチド |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7399464B2 (https=) |
| EP (1) | EP1395684A2 (https=) |
| JP (1) | JP2005500029A (https=) |
| AU (1) | AU2002317867A1 (https=) |
| FR (1) | FR2825716B1 (https=) |
| WO (1) | WO2002101048A2 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7087726B2 (en) | 2001-02-22 | 2006-08-08 | Genentech, Inc. | Anti-interferon-α antibodies |
| FR2822845B1 (fr) * | 2001-03-30 | 2003-12-12 | Genodyssee | Nouveaux polynucleotides comportant des polymorphismes de type snp fonctionnels dans la sequence nucleotidique du gene ifn-alpha-21 ainsi que de nouveaux polypeptides codes par ces polynucleotides et leurs utilisations therapeutiques |
| US7597884B2 (en) * | 2004-08-09 | 2009-10-06 | Alios Biopharma, Inc. | Hyperglycosylated polypeptide variants and methods of use |
| WO2020076992A1 (en) | 2018-10-11 | 2020-04-16 | Inhibrx, Inc. | 5t4 single domain antibodies and therapeutic compositions thereof |
| EP3864045A2 (en) | 2018-10-11 | 2021-08-18 | Inhibrx, Inc. | Dll3 single domain antibodies and therapeutic compositions thereof |
| WO2020077257A1 (en) | 2018-10-11 | 2020-04-16 | Inhibrx, Inc. | Pd-1 single domain antibodies and therapeutic compositions thereof |
| CA3115082A1 (en) | 2018-10-11 | 2020-04-16 | Inhibrx, Inc. | B7h3 single domain antibodies and therapeutic compositions thereof |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH657141A5 (de) | 1980-07-01 | 1986-08-15 | Hoffmann La Roche | Dns-sequenzen, rekombinante expressionsvektoren zur mikrobiellen herstellung von human-leukozyten-interferonen und transformierte mikroorganismen. |
| ZA814375B (en) | 1980-07-01 | 1982-07-28 | Hoffmann La Roche | Interferons and process for their preparation |
| JPH064673B2 (ja) | 1980-11-10 | 1994-01-19 | ゲネンテツク・インコ−ポレ−テツド | ハイブリド型ヒト白血球インタフエロン |
| US4810645A (en) * | 1981-08-14 | 1989-03-07 | Hoffmann-La Roche Inc. | Microbial production of mature human leukocyte interferon K and L |
| EP0072541A3 (en) | 1981-08-14 | 1984-04-18 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them |
| US4801685A (en) * | 1981-08-14 | 1989-01-31 | Hoffmann-La Roche Inc. | Microbial production of mature human leukocyte interferon K and L |
| US4678751A (en) * | 1981-09-25 | 1987-07-07 | Genentech, Inc. | Hybrid human leukocyte interferons |
| GB2108510B (en) | 1981-10-03 | 1984-12-12 | Ciba Geigy Ag | Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof |
| AU1152983A (en) | 1982-01-15 | 1983-07-28 | Cetus Corporation | Interferon alpha 74 |
| US5098703A (en) | 1982-01-15 | 1992-03-24 | Cetus Corporation | Interferon-alpha 76 |
| IE54592B1 (en) | 1982-03-08 | 1989-12-06 | Genentech Inc | Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby |
| CA1217440A (en) | 1982-08-18 | 1987-02-03 | Michael A. Innis | INTERFERON .alpha. 6L |
| IL71555A (en) | 1984-04-15 | 1992-06-21 | State Of Israel Israel Inst Fo | Bovine interferon |
| SE8502430L (sv) | 1985-05-15 | 1986-11-16 | Kabivitrum Ab | En cdna-molekyl som kodar for expressionen av en polypeptid av typen interferon alfa, en bakteriell eller celluler verd transformerad med en sadan molekyl och en polypeptid som uppvisar interferonaktivetet framstelld me |
| SU1703690A1 (ru) | 1986-04-30 | 1992-01-07 | Всесоюзный научно-исследовательский институт генетики и селекции промышленных микроорганизмов | Рекомбинантна плазмидна ДНК @ 22, кодирующа синтез интерферона @ -11 человека, и штамм бактерии РSеUDомоNаS Sp. -продуцент- интерферона @ -11 человека |
| US5780021A (en) * | 1993-03-05 | 1998-07-14 | Georgetown University | Method for treating type 1 diabetes using α-interferon and/or β-i |
| US5789551A (en) * | 1993-06-11 | 1998-08-04 | Pestka Biomedical Laboratories, Inc. | Human leukocyte interferon Hu-IFN-α001 |
| US6001589A (en) * | 1993-06-11 | 1999-12-14 | Pbl Biomedical Laboratories, Inc. | Method of identifying proteins modified by disease states related thereto |
| WO2000039280A2 (en) * | 1998-12-31 | 2000-07-06 | Viragen, Inc. | Leukocyte-derived interferon preparations |
| WO2001025438A2 (en) * | 1999-10-07 | 2001-04-12 | Maxygen, Inc. | Ifn-alpha homologues |
| US20040002474A1 (en) * | 1999-10-07 | 2004-01-01 | Maxygen Inc. | IFN-alpha homologues |
| CA2427850A1 (en) * | 2000-11-03 | 2002-05-10 | Sidney Pestka | Interferons, uses and compositions related thereto |
| JPWO2002069913A1 (ja) | 2001-03-01 | 2004-09-09 | 株式会社クリニカルコスメティック | 皮膚改善用組成物セット |
-
2001
- 2001-06-11 FR FR0107588A patent/FR2825716B1/fr not_active Expired - Fee Related
-
2002
- 2002-06-11 WO PCT/EP2002/007456 patent/WO2002101048A2/en not_active Ceased
- 2002-06-11 JP JP2003503798A patent/JP2005500029A/ja active Pending
- 2002-06-11 AU AU2002317867A patent/AU2002317867A1/en not_active Abandoned
- 2002-06-11 EP EP02747458A patent/EP1395684A2/en not_active Withdrawn
-
2003
- 2003-12-11 US US10/732,485 patent/US7399464B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fletcher et al. | Transcriptomic analysis of the woodchuck model of chronic hepatitis B | |
| Crow et al. | Microarray analysis of interferon-regulated genes in SLE | |
| Kaiser et al. | Differential cytokine responses following Marek's disease virus infection of chickens differing in resistance to Marek's disease | |
| Bataller et al. | Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal | |
| JP2004533240A5 (https=) | ||
| Snoussi et al. | Genetic variation in IL-8 associated with increased risk and poor prognosis of breast carcinoma | |
| Fang et al. | IFNL4: notable variants and associated phenotypes | |
| RU2003133982A (ru) | Новые полинуклеотиды и полипептиды гена ifn альфа-17 | |
| Zhang et al. | Effector CD4+ T cell expression signatures and immune-mediated disease associated genes | |
| JP2017532961A5 (https=) | ||
| Zayed et al. | Association of toll-like receptor 3 and toll-like receptor 9 single nucleotide polymorphisms with hepatitis C virus infection and hepatic fibrosis in egyptian patients | |
| Haugland et al. | Differential expression profiles and gene structure of two tumor necrosis factor-α variants in Atlantic salmon (Salmo salar L.) | |
| JP2005500029A5 (https=) | ||
| Urosevic et al. | Type I IFN innate immune response to adenovirus-mediated IFN-γ gene transfer contributes to the regression of cutaneous lymphomas | |
| JP2004535196A5 (https=) | ||
| CN109504763B (zh) | 用于预测α干扰素治疗乙肝患者疗效的分子标记 | |
| CN114921542A (zh) | 一种与病毒性肝炎抗病毒治疗应答预测相关的snp分子标记及其应用 | |
| CN110734974B (zh) | 一种癌症化疗用药snp位点组合以及检测引物 | |
| JP2025098004A (ja) | マクロファージ刺激１受容体（ｍｓｔ１ｒ）バリアント及びその使用 | |
| Li et al. | Analysis of lncRNA, miRNA, and mRNA expression profiling in type I IFN and type II IFN overexpressed in porcine alveolar macrophages | |
| JP2005500029A (ja) | ＩＦＮα−７遺伝子の新規ポリヌクレオチド及びポリペプチド | |
| Sivaprasad et al. | The distribution of genotype and allelic frequency of IL28B gene polymorphism in Andhra Pradesh, India | |
| Zhang et al. | De novo RNA-seq assembly and differential transcriptome analysis of Carassius auratus gibelio after Cyprinid herpesvirus 2 infection | |
| Grandi et al. | Tumour necrosis factor-308 and-238 promoter polymorphisms are predictors of a null virological response in the treatment of Brazilian hepatitis C patients | |
| CN107312828A (zh) | 与不同肿瘤生长速度肝癌相关的单核苷酸多态性位点及其应用 |